Chuanyuan Wei

2.4k total citations · 1 hit paper
52 papers, 1.6k citations indexed

About

Chuanyuan Wei is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Chuanyuan Wei has authored 52 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 22 papers in Oncology and 16 papers in Cancer Research. Recurrent topics in Chuanyuan Wei's work include Cancer Immunotherapy and Biomarkers (10 papers), MicroRNA in disease regulation (8 papers) and Immunotherapy and Immune Responses (8 papers). Chuanyuan Wei is often cited by papers focused on Cancer Immunotherapy and Biomarkers (10 papers), MicroRNA in disease regulation (8 papers) and Immunotherapy and Immune Responses (8 papers). Chuanyuan Wei collaborates with scholars based in China, Ethiopia and India. Chuanyuan Wei's co-authors include Xuan Yang, Pengfei Zhang, Rui Peng, Jia Fan, Ai‐Wu Ke, Jia‐Cheng Lu, Chao Gao, Fazhi Qi, Guo‐Ming Shi and Meng-Xuan Zhu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Oncogene.

In The Last Decade

Chuanyuan Wei

48 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

PKCα/ZFP64/CSF1 axis resets the tumor microenvironment and fuels anti-PD1 resistance in hepatocellular carcinoma

2022 114 citations Chuanyuan Wei, Meng-Xuan Zhu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chuanyuan Wei China	19	1.1k	729	343	261	241	52	1.6k
Guichun Huang China	24	959 0.9×	636 0.9×	655 1.9×	279 1.1×	239 1.0×	53	1.7k
Marc D. Bullock United Kingdom	21	1.2k 1.1×	934 1.3×	475 1.4×	195 0.7×	185 0.8×	30	1.8k
Jinrong Zhu China	25	1.1k 1.0×	664 0.9×	251 0.7×	201 0.8×	183 0.8×	43	1.5k
Qiong Shao China	17	1.3k 1.1×	1.1k 1.5×	446 1.3×	125 0.5×	219 0.9×	41	1.8k
Leyuan Zhou China	15	843 0.8×	762 1.0×	288 0.8×	259 1.0×	124 0.5×	37	1.3k
Jiewei Chen China	17	901 0.8×	603 0.8×	275 0.8×	146 0.6×	197 0.8×	44	1.3k
Ting Wei China	24	946 0.9×	540 0.7×	529 1.5×	271 1.0×	338 1.4×	55	1.6k
Fulin Qiang China	23	814 0.7×	556 0.8×	349 1.0×	193 0.7×	126 0.5×	37	1.3k
Zhihua Li China	23	919 0.8×	808 1.1×	738 2.2×	254 1.0×	179 0.7×	50	1.6k
Masayuki Hiraki Japan	17	825 0.7×	403 0.6×	464 1.4×	228 0.9×	271 1.1×	58	1.3k

Countries citing papers authored by Chuanyuan Wei

Since Specialization

Citations

This map shows the geographic impact of Chuanyuan Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chuanyuan Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chuanyuan Wei more than expected).

Fields of papers citing papers by Chuanyuan Wei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chuanyuan Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chuanyuan Wei. The network helps show where Chuanyuan Wei may publish in the future.

Co-authorship network of co-authors of Chuanyuan Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Chuanyuan Wei. A scholar is included among the top collaborators of Chuanyuan Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chuanyuan Wei. Chuanyuan Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Lu, et al.. (2025). Application of adoptive cell therapy in malignant melanoma. Journal of Translational Medicine. 23(1). 102–102. 2 indexed citations

Hang, Xiang, Rongkui Luo, Yunzhi Wang, et al.. (2024). Proteogenomic insights into the biology and treatment of pan-melanoma. Cell Discovery. 10(1). 78–78. 3 indexed citations

Gao, Zixu, et al.. (2024). Insights for the immunotherapy in malignant melanoma: a new revolution. 3(1). 2 indexed citations

Wang, Lu, Zixu Gao, Ming Ren, et al.. (2024). Melanoma Derived Exosomes Amplify Radiotherapy Induced Abscopal Effect via IRF7/I‐IFN Axis in Macrophages. Advanced Science. 11(13). e2304991–e2304991. 17 indexed citations

Gao, Zixu, Lu Wang, Zucheng Luo, et al.. (2024). TCTN1 Induces Fatty Acid Oxidation to Promote Melanoma Metastasis. Cancer Research. 85(1). 84–100. 6 indexed citations

Zhu, Yu, Lu Wang, Zixu Gao, et al.. (2024). An advanced comprehensive muti-cell-type-specific model for predicting anti-PD-1 therapeutic effect in melanoma. Theranostics. 14(5). 2127–2150. 5 indexed citations

Zheng, Yi-Min, Yining Wang, Lu Zhou, et al.. (2023). PGAM1 Inhibition Promotes HCC Ferroptosis and Synergizes with Anti‐PD‐1 Immunotherapy. Advanced Science. 10(29). e2301928–e2301928. 54 indexed citations

Song, Wenyu, Hongye Wang, Lu Wang, et al.. (2023). Decoding the metastatic potential and optimal postoperative adjuvant therapy of melanoma based on metastasis score. Cell Death Discovery. 9(1). 397–397. 7 indexed citations

Guo, Xiaojun, Xiaoyong Huang, Xuan Yang, et al.. (2023). Loss of 5-hydroxymethylcytosine induces chemotherapy resistance in hepatocellular carcinoma via the 5-hmC/PCAF/AKT axis. Cell Death and Disease. 14(2). 79–79. 14 indexed citations

10.

Dong, Zhao‐Ru, Jiabin Cai, Guo‐Ming Shi, et al.. (2023). Oncogenic miR-93-5p/Gal-9 axis drives CD8 (+) T-cell inactivation and is a therapeutic target for hepatocellular carcinoma immunotherapy. Cancer Letters. 564. 216186–216186. 10 indexed citations

11.

Wang, Lu, Meng-Xuan Zhu, Ming Ren, et al.. (2022). TRIP13/FLNA Complex Promotes Tumor Progression and Is Associated with Unfavorable Outcomes in Melanoma. Journal of Oncology. 2022. 1–14. 8 indexed citations

12.

Zhang, Simin, et al.. (2021). M2-polarized macrophages mediate wound healing by regulating connective tissue growth factor via AKT, ERK1/2, and STAT3 signaling pathways. Molecular Biology Reports. 48(9). 6443–6456. 44 indexed citations

13.

Wei, Chuanyuan, et al.. (2020). miR-3609 Decelerates the Clearance of Sorafenib in Hepatocellular Carcinoma Cells by Targeting EPAS-1 and Reducing the Activation of the Pregnane X Receptor Pathway. SHILAP Revista de lepidopterología. 1 indexed citations

14.

Zhang, Simin, et al.. (2020). Alda-1, an Aldehyde Dehydrogenase 2 Agonist, Improves Cutaneous Wound Healing by Activating Epidermal Keratinocytes via Akt/GSK-3β/β-Catenin Pathway. Aesthetic Plastic Surgery. 44(3). 993–1005. 14 indexed citations

15.

Huang, Xiaoyong, Pengfei Zhang, Chuanyuan Wei, et al.. (2020). Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p/snail/DPP4 axis. Molecular Cancer. 19(1). 92–92. 178 indexed citations

16.

Peng, Rui, Pengfei Zhang, Xuan Yang, et al.. (2019). Overexpression of RNF38 facilitates TGF-β signaling by Ubiquitinating and degrading AHNAK in hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research. 38(1). 113–113. 45 indexed citations

17.

Wei, Chuanyuan, Yuye Zhang, Yan Zhao, et al.. (2019). CCL14 serves as a novel prognostic factor and tumor suppressor of HCC by modulating cell cycle and promoting apoptosis. Cell Death and Disease. 10(11). 796–796. 62 indexed citations

18.

Wei, Chuanyuan, et al.. (2019). <p>Elevated nuclear auto-antigenic sperm protein promotes melanoma progression by inducing cell proliferation</p>. OncoTargets and Therapy. Volume 12. 2105–2113. 2 indexed citations

19.

Wei, Chuanyuan, Pengfei Zhang, Dongmei Gao, et al.. (2019). Elevated TRIP13 drives the AKT/mTOR pathway to induce the progression of hepatocellular carcinoma via interacting with ACTN4. Journal of Experimental & Clinical Cancer Research. 38(1). 409–409. 58 indexed citations

20.

Wei, Chuanyuan, Lu Wang, Meng-Xuan Zhu, et al.. (2019). TRIM44 activates the AKT/mTOR signal pathway to induce melanoma progression by stabilizing TLR4. Journal of Experimental & Clinical Cancer Research. 38(1). 137–137. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact